ROCKVILLE, MD., Feb. 23, 2016 -- The Regulatory Affairs Professionals Society (RAPS) today launched its global survey of regulatory professionals who work with healthcare and related products. RAPS' Scope of Practice & Compensation Survey of the Regulatory Profession, conducted every two years, is the largest and most comprehensive survey of professionals in this important field, vital to ensuring healthcare products are safe and effective.
Respondents work in the pharmaceutical, biotechnology and medical device industries, government agencies, academia, consultancies and other settings where regulatory expertise is needed. Those completing the 10–15-minute survey answer questions about their jobs, backgrounds and compensation, and all answers are kept confidential and anonymous. The results will be released this summer.
RAPS also is offering participants the option to receive free advance access to the results, as well as a chance to win one of four $250 (US) Amazon gift cards to be given away to respondents over the course of the next two months. In addition, those who have the Regulatory Affairs Certification (RAC) credential also receive one point toward their recertification requirement.
Regulatory professionals located anywhere in the world are invited to complete the survey online at http://ow.ly/YF1mc.
RAPS has conducted similar research on the regulatory profession for more than 25 years. The 2014 survey drew responses from more than 3,300 regulatory professionals in 62 countries. According to the resulting 2014 Scope of Practice & Compensation Report, regulatory professionals' salaries rose an average of 5.4% from 2012 to 2013. RAPS' analysis of the responses showed that job level, regulatory experience, highest-earned degree, total professional experience and having the RAC credential have significant influence on compensation.
The survey results will be very useful to regulatory professionals and talent managers wishing to benchmark salaries and compensation packages. It also provides insight to help RAPS track trends and drive greater awareness and understanding of the importance of the profession.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. http://www.RAPS.org
CONTACT: Zachary Brousseau
Senior Manager, Communications
RAPS
+1 301 770 2920, ext. 245
[email protected]


LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



